Skip to main content
NACFC 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Livestreamed Session
Livestreamed Session
Session is Ticketed (Add-on Session through Registration)
Session is Ticketed (Add-on Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees
Session includes an in person invitee/speaker with CF
Session includes an in person invitee/speaker with CF

Efrat Ozeri-Galai

SpliSense

Efrat Ozeri- Galai, PhD, co-founder and SVP Research and translation of SpilSense, a biotech company developing innovative RNA therapies, based on Antisense Oligonucleotides (ASOs), addressing untreatable genetic illnesses and pulmonary diseases. The first projects of Splisense are concentrating on providing treatment for specific CF patient populations with unmet need which are not trageted or are low responsive to the available CF modulators. Since company establishment I have been leading the research team at Splisense and overseeing early discovery, screening for lead drug candidates and preclinical pharmacology. My background is in human genetics specifically in pulmonary diseases and RNA modulation as well as genetic instability.

Presentation(s):